312 related articles for article (PubMed ID: 16156856)
1. Selective apoptosis of natural killer-cell tumours by l-asparaginase.
Ando M; Sugimoto K; Kitoh T; Sasaki M; Mukai K; Ando J; Egashira M; Schuster SM; Oshimi K
Br J Haematol; 2005 Sep; 130(6):860-8. PubMed ID: 16156856
[TBL] [Abstract][Full Text] [Related]
2. Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma.
Li Y; Zhang X; Hu T; Han L; Li R; Wen J; Zhang M
Oncol Rep; 2014 Aug; 32(2):853-9. PubMed ID: 24913732
[TBL] [Abstract][Full Text] [Related]
3. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Hermanova I; Zaliova M; Trka J; Starkova J
Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
[TBL] [Abstract][Full Text] [Related]
4. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation and reactivation of the asparagine synthetase gene induced by L-asparaginase and ethyl methanesulfonate.
Worton KS; Kerbel RS; Andrulis IL
Cancer Res; 1991 Feb; 51(3):985-9. PubMed ID: 1703043
[TBL] [Abstract][Full Text] [Related]
6. Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities.
Majlessipour F; Kwock R; Martin-Aragon S; Weinberg KI; Avramis VI
Anticancer Res; 2001; 21(1A):11-22. PubMed ID: 11299723
[TBL] [Abstract][Full Text] [Related]
7. Natural killer resistance of a drug-resistant leukemia cell line, mediated by up-regulation of HLA class I expression.
Classen CF; Falk CS; Friesen C; Fulda S; Herr I; Debatin KM
Haematologica; 2003 May; 88(5):509-21. PubMed ID: 12745270
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.
Estes DA; Lovato DM; Khawaja HM; Winter SS; Larson RS
Br J Haematol; 2007 Oct; 139(1):20-30. PubMed ID: 17854304
[TBL] [Abstract][Full Text] [Related]
9. [Temporary effective treatment with L-asparaginase for a patient with refractory nasal NK/T-cell lymphoma].
Sakamoto E; Yamane T; Nakane T; Takeoka Y; Hirose A; Hagihara K; Nakamae H; Ohta K; Hirayama M; Ikura Y; Ohsawa M; Sawada T; Kitoh T; Hino M
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1993-6. PubMed ID: 16282743
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
11. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase.
Kiriyama Y; Kubota M; Takimoto T; Kitoh T; Tanizawa A; Akiyama Y; Mikawa H
Leukemia; 1989 Apr; 3(4):294-7. PubMed ID: 2564453
[TBL] [Abstract][Full Text] [Related]
13. Establishment of real-time polymerase chain reaction method for quantitative analysis of asparagine synthetase expression.
Irino T; Kitoh T; Koami K; Kashima T; Mukai K; Takeuchi E; Hongo T; Nakahata T; Schuster SM; Osaka M
J Mol Diagn; 2004 Aug; 6(3):217-24. PubMed ID: 15269298
[TBL] [Abstract][Full Text] [Related]
14. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
[TBL] [Abstract][Full Text] [Related]
15. Declined asparagine synthetase mRNA expression and enhanced sensitivity to asparaginase in HL-60 cells committed to monocytic differentiation.
Hashimoto K; Suzuki F; Sakagami H
Anticancer Res; 2009 Apr; 29(4):1303-8. PubMed ID: 19414379
[TBL] [Abstract][Full Text] [Related]
16. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines.
Su N; Pan YX; Zhou M; Harvey RC; Hunger SP; Kilberg MS
Pediatr Blood Cancer; 2008 Feb; 50(2):274-9. PubMed ID: 17514734
[TBL] [Abstract][Full Text] [Related]
17. CD45 monoclonal antibody-mediated cytolysis of human NK and T lymphoma cells.
Wulf GG; Boehnke A; Chapuy B; Glass B; Hemmerlein B; Schroers R; Brenner MK; Truemper L
Haematologica; 2006 Jul; 91(7):886-94. PubMed ID: 16818275
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Yamaguchi M; Suzuki R; Kwong YL; Kim WS; Hasegawa Y; Izutsu K; Suzumiya J; Okamura T; Nakamura S; Kawa K; Oshimi K
Cancer Sci; 2008 May; 99(5):1016-20. PubMed ID: 18294294
[TBL] [Abstract][Full Text] [Related]
19. Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines.
Chien WW; Le Beux C; Rachinel N; Julien M; Lacroix CE; Allas S; Sahakian P; Cornut-Thibaut A; Lionnard L; Kucharczak J; Aouacheria A; Abribat T; Salles G
Sci Rep; 2015 Jan; 5():8068. PubMed ID: 25626693
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines].
Li BS; He YY; Luo CY; Jiang H; Shen SH; Jiang LM; Zhang B; Gu LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):559-63. PubMed ID: 20561401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
